Familial adenomatous polyposis is an autosomal dominant disease in which ≥ 100 adenomatous polyps carpet the colon and rectum. The disorder occurs in 1 in 8,000 to 14,000 people. Polyps are present in 50% of patients by age 15 years, and 95% by age 35 years. Cancer develops before age 40 in nearly all untreated patients.
Patients also can develop various extracolonic manifestations (previously termed Gardner syndrome), both benign and malignant. Benign manifestations include desmoid tumors, osteomas of the skull or mandible, sebaceous cysts, and adenomas in other parts of the gastrointestinal tract. Patients are at increased risk of cancer in the duodenum (5 to 11%), pancreas (2%), thyroid (2%), brain (medulloblastoma Medulloblastoma Medulloblastomas are invasive and rapidly growing childhood central nervous system tumors that develop in the posterior fossa (containing the brain stem and cerebellum). Diagnosis is based on... read more in < 1%), and liver (hepatoblastoma Hepatoblastoma Primary liver cancer is usually hepatocellular carcinoma. The first manifestations of liver cancer are usually nonspecific, delaying the diagnosis. When diagnosed at advanced stages, prognosis... read more in 0.7% of children < 5 years).
Symptoms and Signs
Many patients are asymptomatic, but rectal bleeding, typically occult, occurs.
Genetic testing of patient and 1st-degree relatives
Offspring screened for hepatoblastoma
Diagnosis of familial adenomatous polyposis is made by finding > 100 polyps on colonoscopy. Although the characteristic lesions of familial adenomatous polyposis can be recognized on sigmoidoscopy, colonoscopy is usually done to detect a more proximal cancer, which would require evaluation for metastases before treatment.
Diagnosed patients should have genetic testing to identify the specific mutation, which should then be sought in 1st-degree relatives. If genetic testing is unavailable, relatives should be screened with annual sigmoidoscopy beginning at age 12, reducing frequency with each decade. If no polyps are evident by age 50, screening frequency is then the same as for average-risk patients.
Children of parents with familial adenomatous polyposis may be screened for hepatoblastoma from birth to age 5 years with annual serum alpha-fetoprotein levels and possibly liver ultrasound.
Endoscopic surveillance of remainder of gastrointestinal tract
Perhaps nonsteroidal anti-inflammatory drug (NSAIDs)
Colectomy should be done soon after diagnosis. Total proctocolectomy, either with ileostomy or mucosal proctectomy and ileoanal pouch, eliminates the risk of colon and rectal cancer. If subtotal colectomy (removal of most of the colon, leaving the rectum) with ileorectal anastomosis is done, the rectal remnant must be inspected frequently; new polyps must be excised or fulgurated. NSAIDs may inhibit new polyp formation. If new ones appear too rapidly or prolifically to remove, excision of the rectum and permanent ileostomy are needed.
After colectomy, patients should have upper endoscopic surveillance at periodic intervals. The 2015 American College of Gastroenterology's guidelines for genetic testing and management of hereditary gastrointestinal cancer syndromes recommend doing upper endoscopy including duodenoscopy starting at age 25 to 30 years and repeating surveillance every 6 months to 4 years depending on the stage of duodenal polyposis. Annual screening of the thyroid with ultrasound also is recommended.
Familial adenomatous polyposis is an autosomal dominant disease in which ≥ 100 adenomatous polyps carpet the colon and rectum.
Nearly all patients develop colon carcinoma by age 40, so total proctocolectomy is usually done soon after diagnosis.
Patients have an increased risk of other cancers, particularly of the duodenum, and also the pancreas, thyroid, brain, and liver.
After treatment, patients are screened regularly for other cancers and development of polyps in the upper gastrointestinal tract.
Children of parents with familial adenomatous polyposis may be screened for hepatoblastoma from birth to age 5 years.
The following is an English-language resource that may be useful. Please note that THE MANUAL is not responsible for the content of this resource.